Wendy L Dixon is Director of bluebird bio, Inc.. Currently has a direct ownership of 11,894 shares of BLUE, which is worth approximately $92,654. The most recent transaction as insider was on Nov 11, 2021, when has been sold 6,241 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 11.9K
0% 3M change
0% 12M change
Total Value Held $92,654

WENDY L DIXON Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 11 2021
BUY
Other acquisition or disposition
-
6,241 Added 34.41%
11,894 Common Stock
Jun 15 2021
BUY
Grant, award, or other acquisition
-
3,109 Added 26.19%
8,762 Common Stock

Also insider at

INCY
INCYTE CORP Healthcare
ALKS
Alkermes plc. Healthcare
ARVN
ARVINAS, INC. Healthcare
IOVA
IOVANCE BIOTHERAPEUTICS, INC. Healthcare
KMPH
KEMPHARM, INC Healthcare
BDTX
Black Diamond Therapeutics, Inc. Healthcare
WLD

Wendy L Dixon

Director
Cambridge, MA

Track Institutional and Insider Activities on BLUE

Follow bluebird bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLUE shares.

Notify only if

Insider Trading

Get notified when an Bluebird Bio, Inc. insider buys or sells BLUE shares.

Notify only if

News

Receive news related to bluebird bio, Inc.

Track Activities on BLUE